🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of AR-42 when giv...
Status
Completed
Location
Cincinnati Children's Hospital
Start Date
2013-09-17
Trial ID
NCT01798901
Treatments Being Tested
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
The goal of this clinical research study is to compare how 2 different drug...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2014-10-13
Trial ID
NCT02269280
This phase I trial is studying the side effects and best dose of decitabine...
Status
Terminated
Location
Princess Margaret Hospital Phase 2 Consortium
Start Date
2002-09
Trial ID
NCT00049582
Treatments Being Tested
The goal of this clinical trial is to learn if participants treated with th...
Status
Active Not Recruiting
Location
Banner MD Anderson
Start Date
2024-07-22
Trial ID
NCT06384261
Treatments Being Tested
Background: Acute myeloid leukemia (AML) is a cancer of the white blood ce...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-12-16
Trial ID
NCT02996474
Treatments Being Tested
This phase I trial is studying the side effects and best dose of vorinostat...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2006-06
Trial ID
NCT00357708
Treatments Being Tested
A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Status
Completed
Location
Hospital Universitario Príncipe de Asturias
Start Date
2020-11-04
Trial ID
NCT04687761
Treatments Being Tested
STUDY BACKGROUND AND PURPOSE: Acute myelogenous leukemia (AML) is a common...
Status
Terminated
Location
Winship Cancer Institute of Emory University
Start Date
2013-11
Trial ID
NCT02234037
Treatments Being Tested
This study aims to determine whether the recurrence rate of high-risk acute...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-01-01
Trial ID
NCT07101588
Treatments Being Tested